Physician profile
David B Richards
NPI 1982607602
$44,409.76
in general payments reported to CMS, 2019-2025
16 companies · $3,188 in 2025
The $3,188 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,665 · 2020: $6,332 · 2021: $5,034 · 2022: $15K · 2023: $4,562 · 2024: $4,832 · 2025: $3,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,935 · Food and Beverage: $5,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,934.72 |
| Food and Beverage | $5,646.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,754.38 | 2019-2025 | |
| Stryker Corporation | $7,904.68 | 2020-2025 | Triathlon, Blueprint Patient Specific Instrumentation, Tritanium |
| Alpha Orthopedic Systems | $5,924.60 | 2019-2024 | |
| Medical Device Business Services, INC. | $1,610.26 | 2019-2020 | |
| Music City Medical Technologies, LLC | $968.97 | 2024-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $368.33 | 2023-2025 | |
| Depuy Synthes Sales INC. | $315.51 | 2019-2022 | |
| Sanara Medtech INC. | $198.54 | 2025 | Celleraterx |
| Amgen INC. | $195.97 | 2019-2021 | |
| Pacira Therapeutics, INC. | $44.94 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.79 | 2019 | |
| Heron Therapeutics, INC. | $22.55 | 2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $19.50 | 2025 | |
| Djo, LLC | $18.30 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.92 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.